z-logo
open-access-imgOpen Access
Infliximab treatment of glycogenosis Ib with Crohn's-like enterocolitis: A case report
Author(s) -
Y Z Gong,
Xuemei Zhong,
Jizhen Zou
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i19.5280
Subject(s) - medicine , infliximab , enterocolitis , crohn's disease , gastroenterology , disease
Glycogen storage disease type Ib (GSD-Ib) is a glycogen metabolism disorder that leads to the manifestations of inflammatory bowel disease (IBD), especially Crohn's disease (CD)-like colitis. Although biological agents are effective for treating CD, their application in the treatment of GSD-Ib with CD-like colitis has been rarely reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here